Lumida
/SBRA
⌘K
Sabra Health Care REIT Inc

Sabra Health Care REIT Inc

SBRA
$20.52USD-1.49%-0.31 today

MARKET CAP

5.2B

P/E (TTM)

32.6x

FWD P/E

DAY RANGE

$20 – $21

52W RANGE

$17
$23

AI Summary

Stalk
Buy NowMedium

SBRA has broken out decisively above the prior resistance on strong volume, with a Lockout Rally driving continuation demand. In the Stage 2 advancing regime, medium-term bias remains bullish supported by the Momentum Breakout and bullish EMA alignment. Despite overbought RSI, the Lockout Rally override and forced participation dynamics justify immediate participation. Long-term uptrend remains intact above rising SMAs.

  • Same-store managed senior housing revenue +9.6% YoY; cash NOI +14.4%.
  • Senior housing pipeline ~ $690M supports high-yield investments.
  • Negative earnings yield implies valuation may outpace earnings growth.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Sabra Healthcare REIT (NASDAQ: SBRA) is a prominent Real Estate Investment Trust (REIT) focused on the acquisition and management of healthcare-related properties, primarily skilled nursing facilities and senior housing. With a strategic pivot towards managed senior housing, the company is well-positioned to capitalize on the growing demand spurred by an aging population. Their emphasis on quality acquisitions aligns with current market trends, positioning Sabra to thrive within the evolving healthcare landscape.

Bull says

  • Same-store managed senior housing revenue +9.6% YoY; cash NOI +14.4%.
  • Senior housing pipeline ~ $690M supports high-yield investments.
  • Quarterly $0.30 dividend at 75% AFFO payout; 14% cash NOI growth projected for 2026.
  • High dividend yield underscores shareholder return focus and positive revisions.
  • Low beta indicates reduced volatility; positive momentum factors support upside.
  • Aging demographics boost demand for senior housing assets.

Bear says

  • Negative earnings yield implies valuation may outpace earnings growth.
  • Weak profitability factors and elevated leverage risk could strain returns.
  • Occupancy around 88.4% remains volatile; low-90s target uncertain.
  • Medicare/Medicaid reimbursement shifts pose revenue headwinds.
  • High interest-rate sensitivity and institutional skepticism may drag performance.
  • Rising operating costs and competition could compress margins.

Investment themes with SBRA

Nuclear -0.50%

Nuclear energy production and related companies

WELL · PLD · EQIX
Demographics: Elderly Care -0.50%

Services and products for aging population

UCB.BR · JNJ · AZN
Residential REITs -1.05%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 09-12-2026neutral

Transcript signals

Bull points

  • For the second quarter of 2025, we recognized normalized SFO per share of 37 cents and normalized ASO per share of 38 cents compared to 35 cents and 37 cents respectively for the first quarter, which represents a 6% improvement over the same period in 2024.
  • Cash rental income from our triple net portfolio increased $2.3 million from the first quarter as a result of a $1.4 million increase in percentage rents received, with the remainder being primarily driven by contractual annual rent increases.
  • This updated guidance increases our midpoint of normalized FFO and normalized ASFO to $1.46 and $1.50, respectively.

Bear points

  • With the opportunity to develop new inventory constrained by the high cost of capital, building materials, and labor, we do not see a near-term catalyst that will reverse the supply versus demand equation that exists right now.
  • the challenge is that debt rates are about 200 basis points lower than they are here, which means the cap rates are also 150-ish to 200 basis points lower.
  • the challenge is that debt rates are about 200 basis points lower than they are here, which means the cap rates are also 150-ish to 200 basis points lower.
Read full transcript analysis ›